Pre-order Enquiry
Request Free Sample
Healthcare
Aerospace & Defence
Agriculture
Automations
Chemicals & Advanced Materials
Food & Beverages
Information & Communication Technology
Oil & Gas
Power & Energy
Sodium hyaluronate eye drops are also known as 'artificial tears'. They are used to relieve eye dryness and soreness.
Market Analysis and Insights: Global Sodium Hyaluronate Eye Drops Market
Due to the COVID-19 pandemic, the global Sodium Hyaluronate Eye Drops market size is estimated to be worth US$ 309 million in 2021 and is forecast to a readjusted size of US$ 309 million by 2028 with a CAGR of 6.1% during the review period. Fully considering the economic change by this health crisis, by Type accounting for % of the Sodium Hyaluronate Eye Drops global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR in the post-COVID-19 period. While by Type segment is altered to an % CAGR throughout this forecast period.
Global Sodium Hyaluronate Eye Drops key players include URSAPHARM, Santen, Bayer Inc., Bausch & Lomb, Johnson & Johnson, etc. Global top five manufacturers hold a share about 40%.
Asia-Pacific is the largest market, with a share over 45%, followed by North America and Europe, both have a share over 35 percent.
In terms of product, 0.10% is the largest segment, with a share about 40%. And in terms of application, the largest application is Dry Eye, followed by Rewetting.
Global Sodium Hyaluronate Eye Drops Scope and Market Size
The global Sodium Hyaluronate Eye Drops market is segmented by company, region (country), by Type and by Application. Players, stakeholders, and other participants in the global Sodium Hyaluronate Eye Drops market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), by Type and by Application for the period 2017-2028.
Segment by Type
0.001
0.0015
0.003
Others
Segment by Application
Dry Eye
Rewetting
Others
By Region
United States
Europe
China
Japan
Southeast Asia
India
Other Regions
By Company
URSAPHARM Arzneimittel GmbH
Santen
Bayer Inc.
Bausch & Lomb
Johnson & Johnson
The United Laboratories
Alcon
Novax Pharma
Rohto
Thea Pharmaceuticals
Scope Ophthalmics Ltd
Prestige Consumer Healthcare
Medicom Healthcare Ltd
Altacor
Optrex
Market Analysis and Insights: Global Sodium Hyaluronate Eye Drops Market
Due to the COVID-19 pandemic, the global Sodium Hyaluronate Eye Drops market size is estimated to be worth US$ 309 million in 2021 and is forecast to a readjusted size of US$ 309 million by 2028 with a CAGR of 6.1% during the review period. Fully considering the economic change by this health crisis, by Type accounting for % of the Sodium Hyaluronate Eye Drops global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR in the post-COVID-19 period. While by Type segment is altered to an % CAGR throughout this forecast period.
Global Sodium Hyaluronate Eye Drops key players include URSAPHARM, Santen, Bayer Inc., Bausch & Lomb, Johnson & Johnson, etc. Global top five manufacturers hold a share about 40%.
Asia-Pacific is the largest market, with a share over 45%, followed by North America and Europe, both have a share over 35 percent.
In terms of product, 0.10% is the largest segment, with a share about 40%. And in terms of application, the largest application is Dry Eye, followed by Rewetting.
Global Sodium Hyaluronate Eye Drops Scope and Market Size
The global Sodium Hyaluronate Eye Drops market is segmented by company, region (country), by Type and by Application. Players, stakeholders, and other participants in the global Sodium Hyaluronate Eye Drops market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), by Type and by Application for the period 2017-2028.
Segment by Type
0.001
0.0015
0.003
Others
Segment by Application
Dry Eye
Rewetting
Others
By Region
United States
Europe
China
Japan
Southeast Asia
India
Other Regions
By Company
URSAPHARM Arzneimittel GmbH
Santen
Bayer Inc.
Bausch & Lomb
Johnson & Johnson
The United Laboratories
Alcon
Novax Pharma
Rohto
Thea Pharmaceuticals
Scope Ophthalmics Ltd
Prestige Consumer Healthcare
Medicom Healthcare Ltd
Altacor
Optrex
Frequently Asked Questions
This market study covers the global and regional market with an in-depth analysis of the overall growth prospects in the market. Furthermore, it sheds light on the comprehensive competitive landscape of the global market. The report further offers a dashboard overview of leading companies encompassing their successful marketing strategies, market contribution, recent developments in both historic and present contexts.
- By product type
- By End User/Applications
- By Technology
- By Region
The report provides a detailed evaluation of the market by highlighting information on different aspects which include drivers, restraints, opportunities, and threats. This information can help stakeholders to make appropriate decisions before investing.
